Condition
Circulating Tumor Cell clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Circulating Tumor Cell clinical trials that are recruiting, at sites in 5 countries (most in China (5), France (1), Brazil (1)). By phase: Phase 3 (2), Phase 2 (1). The most active sponsors are RenJi Hospital (2), Sixth Affiliated Hospital, Sun Yat-sen University (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 5Countries
Newest Circulating Tumor Cell clinical trials
All recruiting trials (9)
-
Using a 3D culture model to study circulating tumor cells in head and neck cancer
This study is trying to see how circulating tumor cells from patients with head and neck cancer behave in a lab setting to better understand how the cancer spreads and comes back.
-
Enrich circulating tumor cells in metastatic prostate cancer by leukapheresis vs blood sampling
This observational study tests whether leukapheresis can enrich circulating tumor cells more effectively than standard blood draws in men with metastatic prostate cancer.
-
Comparing chemotherapy and observation for liver metastasis in colorectal cancer
This study is testing if some patients with liver metastasis from colorectal cancer can safely skip chemotherapy after surgery and just be monitored instead.
-
Maintenance therapy for colorectal cancer patients after liver surgery
This study is testing if adding maintenance therapy to standard chemotherapy can help colorectal cancer patients with liver metastases live longer without their cancer getting worse after surgery.
-
Evaluating circulating tumor cells in breast cancer after treatment and surgery
This study is testing if collecting and analyzing certain cancer cells from the blood of women with breast cancer after treatment and surgery can help predict their future health outcomes.
-
Liquid biopsy to detect AXL-positive circulating tumor cells in pancreatic cancer
This test tries a blood-based liquid biopsy to see if AXL-positive circulating tumor cells can be found in adults with newly diagnosed metastatic pancreatic cancer who have not yet received treatment.
-
Treatment adjustment for HER2 positive breast cancer after initial therapy
This study is testing if adjusting treatment for early HER2 positive breast cancer based on blood tests can help patients do better after their initial therapy.
-
Using EUS to analyze circulating tumor DNA in gastrointestinal cancer patients
This study is testing if a new way to collect and analyze tumor DNA from the blood of patients with gastrointestinal cancers can help doctors better stage the cancer and monitor for any return after treatment.
-
Detecting how well chemotherapy works in patients with metastatic nasopharyngeal carcinoma using blood tests.
This study is testing if blood tests can help doctors see how well chemotherapy is working for people with metastatic nasopharyngeal carcinoma.
Related topics
Quick answers
How many Circulating Tumor Cell clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (5 trials), France (1 trial), Brazil (1 trial), Taiwan (1 trial), Hong Kong (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.